Silent
Silent provides the tools for seekers to recognize their path and enables self-reliance for spiritual and magickal growth.
Seekers gain insight from his work and find their inner calm from his ability to listen and help others reflect.
2025 Year in Review: Progress in Psychedelic Medicine
Silent • December 29, 2025
The year 2025 marked a consolidating phase in the psychedelic movement. Less spectacle, more infrastructure. Less rhetoric, more data. The field continued its transition from countercultural promise into regulated, clinically grounded practice—particularly around psilocybin as a treatment for trauma, PTSD, anxiety, and addiction.
What distinguished 2025 was not a single sweeping legalization, but the maturation of state-by-state policy, expanded research access, clinician training, and integration frameworks that are now understood as essential rather than optional.
Major U.S. State Initiatives (2025)
Rather than re-litigating early decriminalization victories, 2025 focused on implementation.
Oregon
Continued rollout and refinement of licensed psilocybin service centers. 2025 saw tighter standards around facilitator training, screening protocols, and post-session integration requirements.
Colorado
Finalized regulatory frameworks for natural medicine healing centers. The state emphasized equity licensing, indigenous consultation, and data collection tied to outcomes rather than ideology.
California
While broad decriminalization stalled legislatively, pilot programs tied to veteran mental health, end-of-life distress, and university research quietly expanded under existing research exemptions.
Washington
Advanced psilocybin-assisted therapy task force recommendations, emphasizing medicalized access over retail-style models.
Massachusetts & New York
Focused on
clinical trials and compassionate use pathways, particularly for treatment-resistant depression and trauma-related disorders.
Texas
Continued state-supported research into psychedelic-assisted therapies for veterans, with an emphasis on PTSD and moral injury rather than recreational framing.
The pattern is clear: states are moving slowly, deliberately, and clinically, prioritizing risk management, data, and professional accountability.
Summary of Overall Progress
2025 was a year of credibility building.
Psychedelics are now discussed primarily as therapeutic tools, not cultural symbols.
Regulatory bodies increasingly require integration plans, not just dosing protocols.
Mental health professionals are involved earlier and more deeply in program design.
Insurance and health systems began exploratory conversations—not coverage yet, but modeling.
The movement matured by learning restraint.
Major Research Studies & Institutions
Several research streams continued or expanded in 2025, particularly through organizations such as Johns Hopkins Center for Psychedelic and Consciousness Research, MAPS, and leading university medical centers.
Key areas of study included:
Psilocybin-assisted therapy for treatment-resistant PTSD
Long-term outcomes (12–36 months) for depression and anxiety
Comparative studies between psilocybin, ketamine, and traditional SSRIs
Neuroplasticity markers and default mode network modulation
Group-based therapy models versus individual sessions
Importantly, 2025 emphasized longitudinal data, addressing earlier critiques that psychedelic benefits were “impressive but short-lived.” The emerging picture suggests durability when—and only when—integration is done well.
Clinical Use: Trauma, PTSD, Anxiety, Addiction
By 2025, clinical consensus had sharpened around several observations:
Trauma & PTSD
Psilocybin does not erase trauma. It
reduces avoidance, softens fear responses, and allows memory reconsolidation without overwhelming the nervous system. Clinicians consistently report increased emotional flexibility rather than cathartic release alone.
Anxiety (including end-of-life anxiety)
Benefits correlate strongly with meaning-making, not symptom suppression. Patients report reduced existential fear, increased acceptance, and restored relational capacity.
Addiction
Psilocybin is not an anti-craving drug. Its efficacy lies in disrupting rigid identity narratives (“I am an addict”) and restoring agency, values clarity, and self-trust—when paired with behavioral and community support.
Across all indications, set, setting, and integration remain decisive variables.
The Evolution of Integration Practices
If earlier years were about access, 2025 was about integration becoming its own discipline.
Key shifts:
Integration is now understood as months-long, not a single follow-up session.
Spiritual direction, somatic therapy, and trauma-informed care are increasingly blended.
Journaling, ritual, community processing, and nature-based practices are formally encouraged.
Clinicians recognize that mystical insight without grounding can destabilize rather than heal.
In spiritual direction contexts, integration focuses on:
Meaning rather than interpretation
Embodiment rather than explanation
Relationship repair rather than transcendence chasing
Let me say this plainly: the medicine opens the door; integration teaches you how to live in the house.
Closing Reflection
2025 did not bring a psychedelic revolution. It brought something more valuable: responsibility.
Psilocybin is no longer treated as a miracle or a menace. It is being approached as a powerful, non-ordinary tool that requires humility, ethics, and disciplined care. The conversation has shifted from “Does it work?” to “For whom, under what conditions, and at what cost?”
That is how real healing traditions are born.
And that—quietly—is the most important progress of all.
ABOUT THE AUTHOR
Walk into any forest in the Cascades and you are standing on the dead. The fir that fell forty years ago is now the nurse log feeding a row of saplings. The salmon carried uphill by an eagle became the nitrogen in the cedar's needles. Nothing in that forest is wasted, and nothing in it is afraid. We have built an entire industry on pretending we are exempt from this. We drain the body of its blood, fill it with preservatives, seal it in lacquered hardwood, and lower it into a concrete vault—as if the earth were a contamination to be defended against rather than the place we came from. Cremation, for all its simplicity, burns fossil fuel and sends the body skyward as carbon. There is another way, and it began here in Washington. Human composting—the law calls it natural organic reduction—was legalized in this state in 2019, the first in the nation. The process is unhurried and honest. The body, unembalmed, is laid into a steel vessel and surrounded by wood chips, alfalfa, and straw. No chemicals are added. The microbes that already live on the plant material, and on us, do the work they have always done. Over eight to twelve weeks, the body becomes soil—about a cubic yard of it, dark and alive. Families may take some home for a garden or a tree, or donate it to forest conservation land. What was a person becomes, quite literally, ground for new growth. I have sat with the dying, and I can tell you that the question underneath most deathbed fear is not what happens to me? It is did I matter, and will anything of me remain? The Hávamál answers plainly: cattle die, kin die, the self dies too—but what one leaves behind endures. We usually read that as reputation. I have come to read it more literally. A body that becomes soil leaves something behind that you can hold in your hands. Something that feeds. For those of us who keep the old ways, this is not innovation. It is restoration. Our ancestors were returned to barrows and bogs and burial mounds, given back to the land that fed them. The vessel and the alfalfa are new; the covenant is ancient. The earth gives, and the earth receives. Every harvest festival we keep is built on that exchange. It would be strange to honor the cycle all our lives and then opt out of it at the end. This choice is now legal in a dozen states and counting. If it speaks to you, say so—out loud, in writing, to the people who will one day carry out your wishes. Death plans left unspoken become burdens; death plans spoken become gifts. A leaf falls. A seed sprouts. The tree does not grieve the leaf, and the soil does not refuse the seed. When my own time comes, I intend to be useful one last time. That, too, is a kind of prayer. —Silent
For the Pagan and Contemplative Community
There is a grief that arrives before the death. It does not announce itself. It does not have a name that anyone uses at the dinner table, or in the waiting room, or in the parking lot of the care facility where you sit in your car for a few minutes before going in, gathering yourself. It lives in small moments. The first time they didn't recognize you. The day you realized you were making decisions for them that they would have hated. The night you caught yourself hoping — just for a second, just once — that it would be over soon, and then spent the next three days punishing yourself for the thought. This is called anticipatory grief. And it is real, and it is heavy, and almost no one will name it for you while you are living inside it, because you are the strong one, and the person you are losing is still here, and grief, we have been told, comes after. It doesn't always come after. Sometimes it comes alongside. Caregiving is one of the most demanding things a human being can do. It asks you to be present to someone else's diminishment, day after day, while managing your own fear and your own exhaustion and your own sadness — and while the world around you continues as though nothing unusual is happening. You go to the grocery store. You answer emails. You show up. You are praised for your strength, which is a kindness people offer because they don't know what else to give you. What you actually need is someone who will let you put the strength down for an hour. Not fix you. Not give you a plan. Not tell you that you're doing a great job, or that they couldn't do what you're doing, or that everything happens for a reason. Just someone who will sit with you in the weight of it. Who will not be frightened by what you are carrying. Who will let you say the unsayable things — the anger, the ambivalence, the love that is so tangled up with loss that you can no longer tell them apart. That is what I offer. I am a death doula and spiritual director. I work with caregivers who are in the middle of it — not at the end, not after, but now, in the long middle stretch where the grief has no official start date and the world has not yet given you permission to feel it. We meet, usually by video, for an hour at a time. I listen in a particular way — not for problems to solve, but for what is actually present beneath the exhaustion and the competence and the careful management of everyone else's emotions. You do not have to have it together when you come into this space. That is the point of it. A few things I will not do: I will not tell you how to grieve correctly. There is no correctly. I will not rush you toward acceptance or silver linings. Some things do not have silver linings, and pretending otherwise is a small violence. I will not give you more to manage. You are already managing too much. What I will do is be present — fully, unhurriedly, without an agenda — for whatever you bring into the room. If you are a caregiver and you are reading this and something in you recognized itself in these words, that recognition is an invitation. I have a small number of spaces available for caregivers who are navigating the approach of death alongside someone they love. The intake questions at tokeepsilent.me are where we begin. Or you can reach me directly. There is no script for this conversation. We simply start. — Silent